> The Inflation Reduction Act, enacted in August, set a $35 price cap on insulin products for Medicare recipients. > In 2018, the average price of insulin in t

> The Inflation Reduction Act, enacted in August, set a $35 price cap on insulin products for Medicare recipients. > In 2018, the average price of insulin in the U.S. was 10 times higher than the average price in other wealthy countries, according to a report from the Rand Corporation released in 2021. > "While the current healthcare system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone and that needs to change," David Ricks, chair and CEO of Eli Lilly, said in a statement. The aggressive price cuts we're announcing today should make a real difference for Americans with diabetes," he added. They only did it because a law forced them, then the CEO makes these kind of statements like it comes from corporate benevolence. I hate corporations.